50 results on '"Pandeswara, Srilakshmi"'
Search Results
2. Supplemental Figures S1-4 from Prevention of Carcinogen and Inflammation-Induced Dermal Cancer by Oral Rapamycin Includes Reducing Genetic Damage
3. Data from Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells
4. Data from Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
5. Supplementary Data from IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
6. Data from Biphasic Rapamycin Effects in Lymphoma and Carcinoma Treatment
7. Supplementary Table 2 from IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
8. Supplementary Figures 1 through 11 from Biphasic Rapamycin Effects in Lymphoma and Carcinoma Treatment
9. supplemental figures combined from Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells
10. Supplementary Table 1 from IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
11. Combined supplemental figures 1-7 from Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
12. Supplementary Figures 1-9 from Mitigating Age-Related Immune Dysfunction Heightens the Efficacy of Tumor Immunotherapy in Aged Mice
13. Data from Mitigating Age-Related Immune Dysfunction Heightens the Efficacy of Tumor Immunotherapy in Aged Mice
14. Supplementary Figure Legends 1-9 from Mitigating Age-Related Immune Dysfunction Heightens the Efficacy of Tumor Immunotherapy in Aged Mice
15. IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
16. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells
17. Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative breast cancer
18. Abstract 4513: Notch inhibitors relieve growth suppression by TGF-β and promote growth and metastasis of triple-negative breast cancers
19. Cell-intrinsic and spatially divergent tumor programmed death ligand 1 (PD-L1) signals modify local and systemic anti-tumor immunity through novel chemokine effects
20. Abstract 1958: Opposing roles of Smad2 and Smad3 in the regulation of growth and invasion of TNBC through TMEPAI
21. Abstract 5649: Cell-intrinsic PD-L1 directs tumor initiating cell fate and rapamycin and interferon-γ response
22. Biphasic Rapamycin Effects in Lymphoma and Carcinoma Treatment
23. Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
24. Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
25. Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells
26. Abstract 3024: Targeting TMEPAI/PMEPA1 inhibits triple negative breast cancer cell growth and metastasis by enhancing growth suppressive TGF-β signaling
27. Tumor-intrinsic B7-H1 in melanoma and ovarian cancer regulates mTOR, autophagy and tumor growth
28. Rapamycin directly inhibits T cell lymphoma proliferation at high doses and facilitates immune-independent toxin-mediated killing at a low dose in vivo.
29. Chronic mTOR inhibition in mice with rapamycin alters T , B , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice
30. Abstract 1947: Divergent effects of Smad2 and Smad3 on TGF-β mediated breast cancer cell growth and expression of TMEPAI/PMEPA1
31. Abstract 505: Role of TMEPAI-PTEN-PI3K/Akt axis in TGF-β mediated growth and metastasis of breast cancer cells
32. Parasite Mitogen-Activated Protein Kinases as Drug Discovery Targets to Treat Human Protozoan Pathogens
33. Oral rapamycin (eRapa) requires IFN-γ and promotes γδ T cell cytotoxicity to prevent carcinogen and inflammation-induced dermal cancer (TUM9P.1003)
34. Mammalian target of rapamycin inhibitors are promising T cell lymphoma treatment agents that synergize with ERβ agonists in vitro but not in vivo (VAC3P.1061)
35. Mammalian target of rapamycin inhibition with enterically given rapamycin alters immunity and gut flora in young and aged wild type mice and extends life of immunodeficient mice (IRC8P.452)
36. B7-H1 regulates autoimmunity in αCTLA-4, bm12 transfer and pristane-induced models through distinct sexually dimorphic and non-dimorphic effects (BA4P.128)
37. Abstract P6-12-03: Manumycin A derived nanoparticle induced cytoplasmic vacuolation mediated cell death in triple negative breast cancer
38. Prevention of Carcinogen and Inflammation-Induced Dermal Cancer by Oral Rapamycin Includes Reducing Genetic Damage
39. Abstract LB-259: Interferon-α enhances clinical benefits of regulatory T cell depletion in ovarian cancer through direct T cell effects and by inducing bystander IL-6
40. TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer
41. TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide production
42. Abstract 562: Targeting TMEPAI in breast cancer therapy and prevention
43. Mitigating Age-Related Immune Dysfunction Heightens the Efficacy of Tumor Immunotherapy in Aged Mice
44. Abstract 2280: Role of MAP1LC3 in 15d-PGJ2 induced non-apoptotic and non-autophagic cell death in therapy-resistant triple negative breast tumors
45. Abstract 5179: TMEPAI, a negative regulator of Smad signaling switches tumor suppressive TGF- β to a tumor promoter in breast tumorigenesis
46. A simple method to detect Toxoplasma gondii-specific cytotoxic T cells in vivo
47. Abstract 679: Targeting LC3-SQSTM1 (p62) signaling axis to treat apoptosis-resistant and metastatic breast cancers
48. TgMAPK1 is an important virulence determinant in Toxoplasma gondii affecting stage differentiation. (129.23)
49. Interleukin-12 is dispensable for functional interferon (IFN)-gamma producing CD8+ cytotoxic T cells in Toxoplasma gondii infection (133.28)
50. A simple method to detect Toxopl a sma gondii-specific cytotoxic T cells in vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.